{"id":"W2982882356","doi":"10.25251/skin.3.supp.36","title":"Long-Term Efficacy of Certolizumab Pegol Dosed at 400 mg Every Two Weeks in Patients with Plaque Psoriasis: Pooled 128-Week Data from Two Phase 3 Trials (CIMPASI-1 and CIMPASI-2)","year":2019,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriasis; Plaque psoriasis; Term (time); Internal medicine; Gastroenterology; Dermatology; Adalimumab; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006341808,0.001235122,0.0047562,0.0005110942,0.0004208441,0.001383371,0.0008176079,0.001844685,0.002247369],"category_scores_gemma":[0.004014795,0.0007193856,0.00532168,0.000638181,0.0007725997,0.001370346,0.0004572499,0.003115735,0.0005442913],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006984024,"about_ca_system_score_gemma":0.0007192279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001055823,"about_ca_topic_score_gemma":0.002106926,"domain_scores_codex":[0.9984013,0.0008411154,0.0001624828,0.0002376909,0.000160572,0.0001968335],"domain_scores_gemma":[0.9965739,0.001389776,0.0008533338,0.0004198562,0.000250401,0.0005127087],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.892324,0.002096383,0.007117542,0.002671082,0.02836457,0.0001227453,0.0001211277,0.001817205,0.006200658,0.00007407437,0.001638732,0.05745196],"study_design_scores_gemma":[0.667159,0.1967262,0.09090821,0.000581179,0.036432,0.0003766036,0.0001411734,0.001486024,0.002392327,0.0003964075,0.003270017,0.0001308933],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8959015,0.09487818,0.001370661,0.0008221418,0.0005341914,0.0008696616,0.002585986,0.0001533956,0.002884258],"genre_scores_gemma":[0.9842125,0.01100584,0.0006221872,0.0006519857,0.0003520028,0.0003419112,0.001946927,0.00002637537,0.000840341],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006341808,"threshold_uncertainty_score":0.03353912,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02978723977001265,"score_gpt":0.2982399611446154,"score_spread":0.2684527213746028,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}